Bliss GVS Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Bliss GVS Pharma has a total shareholder equity of ₹10.5B and total debt of ₹832.9M, which brings its debt-to-equity ratio to 7.9%. Its total assets and total liabilities are ₹12.8B and ₹2.3B respectively. Bliss GVS Pharma's EBIT is ₹1.2B making its interest coverage ratio -36.2. It has cash and short-term investments of ₹2.2B.
Key information
7.9%
Debt to equity ratio
₹832.88m
Debt
| Interest coverage ratio | -36.2x |
| Cash | ₹2.20b |
| Equity | ₹10.48b |
| Total liabilities | ₹2.34b |
| Total assets | ₹12.83b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 506197's short term assets (₹8.5B) exceed its short term liabilities (₹1.9B).
Long Term Liabilities: 506197's short term assets (₹8.5B) exceed its long term liabilities (₹418.8M).
Debt to Equity History and Analysis
Debt Level: 506197 has more cash than its total debt.
Reducing Debt: 506197's debt to equity ratio has reduced from 12.9% to 7.9% over the past 5 years.
Debt Coverage: 506197's debt is well covered by operating cash flow (126.1%).
Interest Coverage: 506197 earns more interest than it pays, so coverage of interest payments is not a concern.